Esaote Group participates in ECR 2024 with renewed lines of MRI, US and IT systems, showcasing the new brand identity.

Esaote Group participates in ECR 2024 with renewed lines of MRI, US and IT systems, showcasing the new brand identity.

Vienna, February 28, 2024 - Esaote Group, a leading Italian innovator in medical imaging, is proud to announce its participation in the European Congress of Radiology (ECR) (Vienna, February 28-March 2, Booth 517, Expo Hall 5), showcasing its renovated MRI, Ultrasound, and IT lines.

The two renewed MRI systems – O-scan Smart and G-scan Open – represent an evolution in tradition and confirm Esaote’s excellence in magnetic resonance imaging in over 30 years of innovation, as a result of its constant commitment to research and development together with attentive listening to the needs of the market and users. The systems are updated to comply with the latest regulatory standards, offering advanced performance with image optimization algorithms and optimized clinical protocols (for systems with the eXP package). Updated to the latest Microsoft Office standards, the user interface is also simple and intuitive, making it easier to use, ensuring faster workflow and reducing total examination time.

At the Vienna Congress, Esaote is showcasing its flagship ultrasound system, MyLab™X90 and its latest ultrasound scanner MyLab™A70, which embodies the concept of Agility and is engineered to perform seamlessly in diverse clinical settings. With a compact footprint and a battery-operated lightweight and mobile design, it fulfills the requirements of the healthcare professionals that the product addresses.

At ECR 2024, Esaote is presenting its new brand identity and the new payoff of “Health with Care” that aligns its vision, mission and core values to mark a significant stride towards the sense of care and empathy with which Esaote approaches its everyday work, to improve people’s well-being.

*O-scan Smart and G-scan Open are soon due to receive CE marking and FDA approval.

**MyLab™A70 is 510(k) pending at the FDA. Not available for sale in the United States.

Esaote Group: Leader in medical imaging (ultrasound, magnetic resonance, software to manage the diagnostic process). At the end of 2023, the Group had 1,250 employees, half of which are based in Italy. With headquarters in Genoa and Florence and its own production and research units in Italy and the Netherlands, Esaote maintains a presence in more than 100 countries around the world.

Further information available at: www.esaote.com

Esaote Unveils two new Ultrasound Systems at Arab Health: MyLab™A50 and MyLab™A70

Agile solutions to increase the access to ultrasound imaging and support the users in challenging clinical settings. Vienna, February 28, 2024 - Esaote Group, a leading Italian innovator in medical imaging, is proud to announce its participation in the European Congress of Radiology (ECR) (Vienna, February 28-March 2, Booth 517, Expo Hall 5), showcasing its renovated MRI, Ultrasound, and IT lines. The two renewed MRI systems – O-scan Smart and G-scan Open – represent an evolution in tradition and confirm Esaote’s excellence in magnetic resonance imaging in over 30 years of innovation, as a result of its constant commitment to research and development together with attentive listening to the needs of the market and users. The systems are updated to comply with the latest regulatory standards, offering advanced performance with image optimization algorithms and optimized clinical protocols (for systems with the eXP package). Updated to the latest Microsoft Office standards, the user interface is also simple and intuitive, making it easier to use, ensuring faster workflow and reducing total examination time. At the Vienna Congress, Esaote is showcasing its flagship ultrasound system, MyLab™X90 and its latest ultrasound scanner MyLab™A70, which embodies the concept of Agility and is engineered to perform seamlessly in diverse clinical settings. With a compact footprint and a battery-operated lightweight and mobile design, it fulfills the requirements of the healthcare professionals that the product addresses. At ECR 2024, Esaote is presenting its new brand identity and the new payoff of “Health with Care” that aligns its vision, mission and core values to mark a significant stride towards the sense of care and empathy with which Esaote approaches its everyday work, to improve people’s well-being. *O-scan Smart and G-scan Open are soon due to receive CE marking and FDA approval. **MyLab™A70 is 510(k) pending at the FDA. Not available for sale in the United States. Esaote Group: Leader in medical imaging (ultrasound, magnetic resonance, software to manage the diagnostic process). At the end of 2023, the Group had 1,250 employees, half of which are based in Italy. With headquarters in Genoa and Florence and its own production and research units in Italy and the Netherlands, Esaote maintains a presence in more than 100 countries around the world. Further information available at: www.esaote.com